参考文献/References:
[1]Mendes AC,Baran ET,Lisboa P,et al.Microfluidic fabrication of self-assembled peptide-polysaccharide microcapsules as 3D environments for cell culture[J].Biomacromolecules,2012,13(12):4039-4048.[2]Pinto B,Henriques AC,Silva PMA,et al.Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research[J].Pharmaceutics,2020,12(12):1186.[3]Schutgens F,Clevers H.Human Organoids:Tools for Understanding Biology and Treating Diseases[J].Annu Rev Pathol,2020,15:211-234.[4]Bersani F,Morena D,Picca F,et al.Future perspectives from lung cancer pre-clinical models:new treatments are coming?[J].Transl Lung Cancer Res,2020,9(6):2629-2644.[5]Corrò C,Novellasdemunt L,Li VSW.A brief history of organoids[J].Am J Physiol Cell Physiol,2020,319(1):C151-c165.[6]余金,张殿龙,韩芳,等.乳腺癌类器官构建与临床转化应用[J].中华实验外科杂志,2020,37(12):2354-2357.[7]冯紫伊,梁珊珊,于炜婷,等.患者来源肿瘤类器官的培养与研究及应用[J].中国组织工程研究,2021,25(25):4082-4088.[8]Qian X,Song H,Ming GL.Brain organoids:advances,applications and challenges[J].Development,2019,146(8):dev166074.[9]Nugraha B,Buono MF,Von Boehmer L,et al.Human Cardiac Organoids for Disease Modeling[J].Clin Pharmacol Ther,2019,105(1):79-85.[10]Almeqdadi M,Mana MD,Roper J,et al.Gut organoids:mini-tissues in culture to study intestinal physiology and disease[J].Am J Physiol Cell Physiol,2019,317(3):C405-C419.[11]Prior N,Inacio P,Huch M.Liver organoids:from basic research to therapeutic applications[J].Gut,2019,68(12):2228-2237.[12]Nishinakamura R.Human kidney organoids:progress and remaining challenges[J].Nat Rev Nephrol,2019,15(10):613-624.[13]Bourguignon C,Vernisse C,Mianné J,et al.Lung organoids[J].Med Sci (Paris),2020,36(4):382-388.[14]van der Vaart J,Clevers H.Airway organoids as models of human disease[J].J Intern Med,2021,289(5):604-613. [15]Mcqualter JL,Yuen K,Williams B,et al.Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung[J].Proc Natl Acad Sci U S A,2010,107(4):1414-1419.[16]Leeman KT,Pessina P,Lee JH,et al.Mesenchymal Stem Cells Increase Alveolar Differentiation in Lung Progenitor Organoid Cultures[J].Sci Rep,2019,9(1):6479.[17]Tan Q,Choi KM,Sicard D,et al.Human airway organoid engineering as a step toward lung regeneration and disease modeling[J].Biomaterials,2017,113:118-132.[18]Kim M,Mun H,Sung CO,et al.Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening[J].Nat Commun,2019,10(1):3991.[19]Guterres A,De Azeredo Lima CH,Miranda RL,et al.What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?[J].Infect Genet Evol,2020,85:104417.[20]Sui JSY,Martin P,Gray SG.Pre-clinical models of small cell lung cancer and the validation of therapeutic targets[J].Expert Opin Ther Targets,2020,24(3):187-204.[21]Leibel SL,Sun X.Halting SARS-CoV-2:lung organoids step up to the plate[J].Embo j,2021,40(5):e107651.[22]Katsura H,Sontake V,Tata A,et al.Human Lung Stem Cell-Based Alveolospheres Provide Insights into SARS-CoV-2-Mediated Interferon Responses and Pneumocyte Dysfunction[J].Cell Stem Cell,2020,27(6):890-904.e8.[23]Ebisudani T,Sugimoto S,Haga K,et al.Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening[J].Cell Rep,2021,35(10):109218.[24]Sachs N,Papaspyropoulos A,Zomer-Van Ommen DD,et al.Long-term expanding human airway organoids for disease modeling[J].EMBO J,2019,38(4):e100300.[25]Harford TJ,Rezaee F,Dye BR,et al.RSV-induced changes in a 3-dimensional organoid model of human fetal lungs[J].PLoS One,2022,17(3):e0265094.[26]Yin Y,Bijvelds M,Dang W,et al.Modeling rotavirus infection and antiviral therapy using primary intestinal organoids[J].Antiviral Res,2015,123:120-131.[27]Nakamura H,Sugano M,Miyashita T,et al.Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells[J].Lung Cancer,2019,134:100-107.[28]Li YF,Gao Y,Liang BW,et al.Patient-derived organoids of non-small cells lung cancer and their application for drug screening[J].Neoplasma,2020,67(2):430-437.[29]Wang Y,Jiang T,Qin Z,et al.HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib[J].Ann Oncol,2019,30(3):447-455.[30]Wu X,Van Dijk EM,Ng-Blichfeldt JP,et al.Mesenchymal WNT-5A/5B Signaling Represses Lung Alveolar Epithelial Progenitors[J].Cells,2019,8(10):1147.[31]Wang A,Zhang Q,Wang Y,et al.Inhibition of Gabrp reduces the differentiation of airway epithelial progenitor cells into goblet cells[J].Exp Ther Med,2021,22(1):720.[32]Pouwels SD,Hesse L,Wu X,et al.LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE[J].Am J Physiol Lung Cell Mol Physiol,2021,321(4):L641-L652.[33]Mccauley KB,Hawkins F,Serra M,et al.Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling[J].Cell Stem Cell,2017,20(6):844-857.e6.[34]Chen YW,Huang SX,De Carvalho A,et al.A three-dimensional model of human lung development and disease from pluripotent stem cells[J].Nat Cell Biol,2017,19(5):542-549.